Differential requirement of perforin and IFN-γ in CD8 T cell-mediated immune responses against B16.F10 melanoma cells expressing a viral antigen

被引:0
作者
Prévost-Blondel, A [1 ]
Neuenhahn, M [1 ]
Rawiel, M [1 ]
Pircher, H [1 ]
机构
[1] Univ Freiburg, Dept Immunol, Inst Med Microbiol & Hyg, D-79104 Freiburg, Germany
关键词
perforin; IFN-gamma; CD8 T cell; B16; melanoma; immunotherapy;
D O I
10.1002/1521-4141(200009)30:9<2507::AID-IMMU2507>3.0.CO;2-V
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Perforin-mediated lysis and secretion of IFN-gamma belong to the key effector functions of CD8 T cells. To compare the anti-tumor activity of these two mechanisms, we used B16.F10 mela- noma cells (B16(GP33)) expressing the cytotoxic T cell epitope GP33 and T cell receptor transgenic (TCR-tg) mice specific for GP33 and deficient in perforin or IFN-gamma. B16(GP33) tumor cells, injected either i.v. to induce experimental metastases or s.c., were similarly controlled in both wild-type and perforin-deficient, but not in IFN-gamma-deficient TCR-tg mice. A similar result was obtained when the therapeutic efficacy of adoptively transferred TCR-tg effector cells from these mice was examined in the corresponding perforin- or IFN-gamma-deficient C57BL/6 hosts. Criss-cross experiments further revealed that IFN-gamma production by the host strongly influenced the efficiency of the adoptively transferred effector cells. In contrast to the potent ability of GP33-specific effector cells to mediate B16(GP33) tumor regression without perforin, GP33-specific memory cells, induced with recombinant vaccinia virus expressing GP33, failed to control B16(GP33) tumor growth in the absence of perforin. In conclusion, our data demonstrate a crucial role for IFN-gamma in B16(GP33) tumor cell elimination in vivo and indicate a differential requirement of perforin by effector versus memory CD8 T cells in anti-tumor immunity.
引用
收藏
页码:2507 / 2515
页数:9
相关论文
共 37 条
[1]   The IFN gamma receptor: A paradigm for cytokine receptor signaling [J].
Bach, EA ;
Aguet, M ;
Schreiber, RD .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :563-&
[2]   INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR HAVE A ROLE IN TUMOR REGRESSIONS MEDIATED BY MURINE CD8+ TUMOR-INFILTRATING LYMPHOCYTES [J].
BARTH, RJ ;
MULE, JJ ;
SPIESS, PJ ;
ROSENBERG, SA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (03) :647-658
[3]   Cellular responses to interferon-gamma [J].
Boehm, U ;
Klamp, T ;
Groot, M ;
Howard, JC .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :749-795
[4]  
Böhm W, 1998, J IMMUNOL, V161, P897
[5]   Coupling and uncoupling of tumor immunity and autoimmunity [J].
Bowne, WB ;
Srinivasan, R ;
Wolchok, JD ;
Hawkins, WG ;
Blachere, NE ;
Dyall, R ;
Lewis, JJ ;
Houghton, AN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (11) :1717-1722
[6]   MULTIPLE DEFECTS OF IMMUNE CELL-FUNCTION IN MICE WITH DISRUPTED INTERFERON-GAMMA GENES [J].
DALTON, DK ;
PITTSMEEK, S ;
KESHAV, S ;
FIGARI, IS ;
BRADLEY, A ;
STEWART, TA .
SCIENCE, 1993, 259 (5102) :1739-1742
[7]   Type 1 and type 2 CD8+ effector T cell subpopulations promote long-term tumor immunity and protection to progressively growing tumor [J].
Dobrzanski, MJ ;
Reome, JB ;
Dutton, RW .
JOURNAL OF IMMUNOLOGY, 2000, 164 (02) :916-925
[8]  
Fallarino F, 1999, J IMMUNOL, V163, P4109
[9]  
Farrar JD, 1999, J IMMUNOL, V162, P2842
[10]  
FERNANDEZCRUZ E, 1979, J IMMUNOL, V123, P1772